Baylor Sammons Cancer Center / Albany Medical Center / Mountain Cancer Center / The University of Texas Health Science Center / Baylor College of Medicine / Dallas Presbyterian Hospital / Memorial City / /
IndustryTerm
therapy for metastatic disease / Cancer Therapy / care for patients with breast cancer / treatment for metastatic breast cancer / treatment of chronic myelogenous leukemia / Cancer Care / /
MedicalCondition
measureable disease / clinical cancer / nausea / metastatic disease / fatigue / metastatic breast cancer / HER2-negative metastatic breast cancer / breast cancer / ER+breast cancer / cancer metastasis / Cancer / disease / HER2-negative breast cancer / progressive disease / initial breast cancer / bone metastases / breast tumors / pleural effusion / HER2negative metastatic breast cancer / chronic myelogenous leukemia / stable disease / rash / postmenopausal metastatic breast cancer / anemia / /
MedicalTreatment
endocrine therapy / chemotherapy / surgery / /
Organization
Cancer Therapy & Research Center / 2Rocky Mountain Cancer Center / Christiansburg Office / Albany Medical Center / 5Texas Oncology-Baylor Sammons Cancer Center / Baylor College of Medicine / U.S. Food and Drug Administration / Dallas Presbyterian Hospital / American Association for Cancer Research / University of Texas Health Science Center at San Antonio / /
Person
Frankie Ann / Dev Paul / Jeremy Moore / Liz May / / /
Product
letrozole / /
ProvinceOrState
Texas / Virginia / Arizona / Colorado / /
PublishedMedium
Cancer Research / /
Technology
artificial intelligence / chemotherapy / treating cancer / /
Embargoed for Release: 7:30 a.m. CT, Dec. 12, 2013 To interview Dev Paul, contact Liz May at [removed] or[removed]For a photo of Dev Paul, click here. For other inquiries, contact Jeremy Moore at jerem